These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28975638)

  • 1. The roles of alcohol dehydrogenase in patients with atrial fibrillation.
    Hu YF; Chang YT; Lin YJ; Chang SL; Lo LW; Huang YH; Liu TT; Chen CH; Tuan TC; Chao TF; Chung FP; Liao JN; Te ALD; Huang CF; Chen SA
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1446-1453. PubMed ID: 28975638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations of aldehyde dehydrogenase 2 and alcohol dehydrogenase 1B are associated with the etiology of atrial fibrillation in Japanese.
    Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Matsumura H; Tomomori S; Amioka M; Hironomobe N; Motoda C; Oda N; Chayama K; Chen CH; Gross ER; Mochly-Rosen D; Kihara Y
    J Biomed Sci; 2016 Dec; 23(1):89. PubMed ID: 27927211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation.
    Wu CH; Hu YF; Chou CY; Lin YJ; Chang SL; Lo LW; Tuan TC; Li CH; Chao TF; Chung FP; Liao JN; Chen SA
    Heart Rhythm; 2013 Jan; 10(1):10-5. PubMed ID: 22982967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue growth factor: a predictor of recurrence after catheter ablation in patients with nonparoxysmal atrial fibrillation.
    Song ZP; Liu X; Zhang DD
    Pacing Clin Electrophysiol; 2014 May; 37(5):630-7. PubMed ID: 24467520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation.
    Wutzler A; Kestler C; Perrot A; Loehr L; Huemer M; Parwani AS; Attanasio P; Özcelik C; Schunck WH; Gollasch M; Haverkamp W; Boldt LH
    Int J Cardiol; 2013 Oct; 168(4):3647-51. PubMed ID: 23711456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation.
    Ueberham L; Bollmann A; Shoemaker MB; Arya A; Adams V; Hindricks G; Husser D
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):732-7. PubMed ID: 23876437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Alcohol Consumption on the Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Takahashi Y; Okubo K; Nakashima E; Watari Y; Nakajima J; Yamao K; Osaka Y; Tanaka Y; Kimura S; Takagi K; Hikita H; Hirao K; Isobe M
    J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27895043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data.
    Husser D; Büttner P; Ueberham L; Dinov B; Sommer P; Arya A; Hindricks G; Bollmann A
    J Transl Med; 2017 Apr; 15(1):71. PubMed ID: 28381281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Single Nucleotide Polymorphisms in Korean Patients with Early-onset Atrial Fibrillation after Catheter Ablation.
    Park YM; Roh SY; Lee DI; Shim J; Choi JI; Park SW; Kim YH
    J Korean Med Sci; 2020 Dec; 35(49):e411. PubMed ID: 33350184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.
    Choi JI; Baek YS; Roh SY; Piccini JP; Kim YH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1904-1913. PubMed ID: 31393025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease.
    Zhong Y; Tang K; Li H; Zhao D; Kou W; Xu S; Zhang J; Yang H; Li S; Guo R; Peng W; Xu Y
    Circ J; 2019 Sep; 83(10):1994-2001. PubMed ID: 31406021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up.
    Chao TF; Tsao HM; Lin YJ; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):514-20. PubMed ID: 22550126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation.
    Miyazaki S; Ebana Y; Liu L; Nakamura H; Hachiya H; Taniguchi H; Takagi T; Kajiyama T; Watanabe T; Igarashi M; Kusa S; Niida T; Iesaka Y; Furukawa T
    Int J Cardiol; 2017 Oct; 244():151-157. PubMed ID: 28637626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient.
    Yang PS; Kim TH; Uhm JS; Park S; Joung B; Lee MH; Pak HN
    Europace; 2016 Nov; 18(11):1711-1718. PubMed ID: 26838688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.
    Pinto Teixeira P; Martins Oliveira M; Ramos R; Rio P; Silva Cunha P; Delgado AS; Pimenta R; Cruz Ferreira R
    J Interv Card Electrophysiol; 2017 Aug; 49(2):165-171. PubMed ID: 28567579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between CHADS2 score and long-term atrial fibrillation recurrence rate after catheter ablation].
    Hu X; Wang Q; Sun J; Feng X; Zhang P; Liu B; Wang J; Zhang R; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):379-83. PubMed ID: 25042914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.